The results of this analysis clearly show that patients on sulphonylurea with high HbA1c, eGFR below 50 ml/min/1.73 m2, and diabetes duration longer than 5 years are at very high risk to start insulin treatment during follow-up. The gene discussed is INS; the disease is diabetes mellitus.